• Login
    View Item 
    •   Home
    • Research
    • Articles
    • View Item
    •   Home
    • Research
    • Articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of KAUSTCommunitiesIssue DateSubmit DateThis CollectionIssue DateSubmit Date

    My Account

    Login

    Quick Links

    Open Access PolicyORCID LibguideTheses and Dissertations LibguideSubmit an Item

    Statistics

    Display statistics

    Accelerating early anti-tuberculosis drug discovery by creating mycobacterial indicator strains that predict mode of action

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Antimicrob. Agents Chemother.-2018-Boot-AAC.00083-18.pdf
    Size:
    3.089Mb
    Format:
    PDF
    Description:
    Accepted Manuscript
    Download
    Type
    Article
    Authors
    Boot, Maikel
    Commandeur, Susanna
    Subudhi, Amit
    Bahira, Meriem
    Smith, Trever C.
    Abdallah, Abdallah
    van Gemert, Mae
    Lelièvre, Joël
    Ballell, Lluís
    Aldridge, Bree B.
    Pain, Arnab cc
    Speer, Alexander
    Bitter, Wilbert cc
    KAUST Department
    Biological and Environmental Sciences and Engineering (BESE) Division
    Bioscience Program
    NGS, qPCR and Single Cell Genomics
    Date
    2018-06-26
    Online Publication Date
    2018-06-26
    Print Publication Date
    2018-04-16
    Permanent link to this record
    http://hdl.handle.net/10754/627598
    
    Metadata
    Show full item record
    Abstract
    Due to the rise of drug resistant forms of tuberculosis there is an urgent need for novel antibiotics to effectively combat these cases and shorten treatment regimens. Recently, drug screens using whole cell analyses have been shown to be successful. However, current high-throughput screens focus mostly on stricto sensu life-death screening that give little qualitative information. In doing so, promising compound scaffolds or non-optimized compounds that fail to reach inhibitory concentrations are missed. To accelerate early TB drug discovery, we performed RNA sequencing on Mycobacterium tuberculosis and Mycobacterium marinum to map the stress responses that follow upon exposure to sub-inhibitory concentrations of antibiotics with known targets: ciprofloxacin, ethambutol, isoniazid, streptomycin and rifampicin. The resulting dataset comprises the first overview of transcriptional stress responses of mycobacteria to different antibiotics. We show that antibiotics can be distinguished based on their specific transcriptional stress fingerprint. Notably, this fingerprint was more distinctive in M. marinum. We decided to use this to our advantage and continue with this model organism. A selection of diverse antibiotic stress genes was used to construct stress reporters. In total, three functional reporters were constructed to respond to DNA damage, cell wall damage and ribosomal inhibition. Subsequently, these reporter strains were used to screen a small anti-TB compound library to predict the mode of action. In doing so, we could identify the putative mode of action for three novel compounds, which confirms our approach.
    Citation
    Boot M, Commandeur S, Subudhi AK, Bahira M, Smith TC, et al. (2018) Accelerating early anti-tuberculosis drug discovery by creating mycobacterial indicator strains that predict mode of action. Antimicrobial Agents and Chemotherapy: AAC.00083–18. Available: http://dx.doi.org/10.1128/aac.00083-18.
    Sponsors
    The authors would like to express their gratitude to Christina M.J.E. Vandenbroucke-Grauls for helpful discussions. We would like to thank Francois Rustenburg and Coen Kuijl for technical assistance. The research leading to these results has received funding from the Innovative Medicines Initiative Joint Undertaking under grant agreement n°115337, resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in-kind contribution. The grant was awarded to WB. This work was additionally supported by NIH grants (DP2LM011952 to BBA and T32 AI 7329-23). This work was supported by the Netherlands Organization for Scientific Research (NWO) through a VENI grant (016.Veni.171.090) awarded to ASp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that they have no conflicts of interest with the contents of this article.
    Publisher
    American Society for Microbiology
    Journal
    Antimicrobial Agents and Chemotherapy
    DOI
    10.1128/aac.00083-18
    PubMed ID
    29661879
    Additional Links
    http://aac.asm.org/content/early/2018/04/10/AAC.00083-18
    ae974a485f413a2113503eed53cd6c53
    10.1128/aac.00083-18
    Scopus Count
    Collections
    Articles; Biological and Environmental Science and Engineering (BESE) Division; Bioscience Program

    entitlement

     
    DSpace software copyright © 2002-2022  DuraSpace
    Quick Guide | Contact Us | KAUST University Library
    Open Repository is a service hosted by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items. For anonymous users the allowed maximum amount is 50 search results.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.